High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Past Returns: Outperforming stock! In past three years, the stock has provided 53.6% return compared to 13.3% by NIFTY 50.
Profitability: Very strong Profitability. One year profit margin are 21%.
Smart Money: Smart money has been increasing their position in the stock.
Balance Sheet: Strong Balance Sheet.
Technicals: SharesGuru indicator is Bearish.
Momentum: Stock is suffering a negative price momentum. Stock is down -7.6% in last 30 days.
Dilution: Company has been diluting it's stock to raise money for business.
Valuation | |
|---|---|
| Market Cap | 2.3 kCr |
| Price/Earnings (Trailing) | 13.98 |
| Price/Sales (Trailing) | 18 |
| EV/EBITDA | 117.84 |
| Price/Free Cashflow | -7.17 |
| MarketCap/EBT | 159.04 |
| Enterprise Value | 2.3 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 127.74 Cr |
| Rev. Growth (Yr) | -82.1% |
| Earnings (TTM) | 26.39 Cr |
| Earnings Growth (Yr) | 9.56% |
Profitability | |
|---|---|
| Operating Margin | 20% |
| EBT Margin | 11% |
| Return on Equity | 7.8% |
| Return on Assets | 6.93% |
| Free Cashflow Yield | -13.96% |
Growth & Returns | |
|---|---|
| Price Change 1W | -7.7% |
| Price Change 1M | -7.6% |
| Price Change 6M | -67.9% |
| Price Change 1Y | -55.7% |
| 3Y Cumulative Return | 53.6% |
| 5Y Cumulative Return | 69.2% |
| 7Y Cumulative Return | 34.8% |
| 10Y Cumulative Return | 24.3% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -125.36 Cr |
| Cash Flow from Operations (TTM) | -86.25 Cr |
| Cash Flow from Financing (TTM) | 314.92 Cr |
| Cash & Equivalents | 12.4 Cr |
| Free Cash Flow (TTM) | -86.25 Cr |
| Free Cash Flow/Share (TTM) | -13.3 |
Balance Sheet | |
|---|---|
| Total Assets | 380.66 Cr |
| Total Liabilities | 42.13 Cr |
| Shareholder Equity | 338.53 Cr |
| Current Assets | 36.4 Cr |
| Current Liabilities | 22.51 Cr |
| Net PPE | 22.58 Cr |
| Inventory | 5.25 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.05 |
| Debt/Equity | 0.05 |
| Interest Coverage | 3 |
| Interest/Cashflow Ops | -95.53 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 0.00 |
| Dividend Yield | 0.01% |
| Shares Dilution (1Y) | 21.2% |
| Shares Dilution (3Y) | 37.6% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Past Returns: Outperforming stock! In past three years, the stock has provided 53.6% return compared to 13.3% by NIFTY 50.
Profitability: Very strong Profitability. One year profit margin are 21%.
Smart Money: Smart money has been increasing their position in the stock.
Balance Sheet: Strong Balance Sheet.
Technicals: SharesGuru indicator is Bearish.
Momentum: Stock is suffering a negative price momentum. Stock is down -7.6% in last 30 days.
Dilution: Company has been diluting it's stock to raise money for business.
Investor Care | |
|---|---|
| Dividend Yield | 0.01% |
| Dividend/Share (TTM) | 0.00 |
| Shares Dilution (1Y) | 21.2% |
| Earnings/Share (TTM) | 2.54 |
Financial Health | |
|---|---|
| Current Ratio | 1.62 |
| Debt/Equity | 0.05 |
Technical Indicators | |
|---|---|
| RSI (14d) | 18.67 |
| RSI (5d) | 0.00 |
| RSI (21d) | 46.97 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Sell |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of FISCHER MEDICAL VENTURES's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand FISCHER MEDICAL VENTURES ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| FMV Holdings Pte Ltd | 51.16% |
| Shankar Varadharajan | 10.64% |
| ROOPAL HITESH KAWA | 2.74% |
| Vikasa India EIF I Fund | 2.57% |
| India Energing Gaints Fund Limited | 2.23% |
| VINAY RAJENDRAKUMAR NAGDA | 1.54% |
| Blue Lotus Capital Multi Bagger Fund II | 1.36% |
| SURIYAMOORTHY SHANMUGAVEL | 1.32% |
| L7 HITECH PRIVATE LIMITED | 1.24% |
| KAUSHIK HASMUKHLAL GANDHI | 1.23% |
| NATWARLAL KESHAVJIBHAI KAWA | 1.19% |
| HITESH NATWARLAL KAWA | 1.1% |
| Corporate Body- Broker | 0.01% |
| Ravindran Govindan | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of FISCHER MEDICAL VENTURES against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| POLYMED | Poly Medicure | 13.78 kCr | 1.91 kCr | -14.30% | -38.60% | 39.8 | 7.23 | - | - |
| TTKHLTCARE | TTK Healthcare | 1.22 kCr | 902.73 Cr | -10.20% | -28.40% | 20.25 | 1.35 | - | - |
| HSIL | Hemant Surgical Industries | 697.42 Cr | - | -16.40% | -25.80% | 113.09 | - | - | - |
| OPTOCIRCUI | Opto Circuits (India) | 53.51 Cr | - | 0.00% | 0.00% | - | - | - | - |
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.